A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P. Mohammad, Ryan G. Kruger, Jiri Kasparec et al.|Cancer Cell|2015Cited by 518
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor ModelsAnastasia Wyce, Peter J. Tummino, Gopinath Ganji et al.|PLoS ONE|2013Cited by 205
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancerAnastasia Wyce, Olena Barbash, Yan Degenhardt et al.|Oncotarget|2013Cited by 179
A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) HypertrimethylationHeidi M. Ott, Michael T. McCabe, Alan P. Graves et al.|Molecular Cancer Therapeutics|2014Cited by 46
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cellsYuchen Bai, Charbel Darido|Nature Communications|2023Cited by 37